{"id":269277,"date":"2022-06-30T11:00:41","date_gmt":"2022-06-30T05:30:41","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=269277"},"modified":"2022-07-07T16:48:34","modified_gmt":"2022-07-07T11:18:34","slug":"kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/","title":{"rendered":"Kerala High Court| Consider compulsory licensing of breast cancer drug Ribociclib; HC directs Central Government"},"content":{"rendered":"
\n

Kerala High Court<\/span>: While adjudicating a petition filed by a breast cancer patient seeking to afford life-saving medicines which otherwise cost more than twice her monthly income, V. G. Arun, J. directed Central Government to consider compulsory licensing of the breast cancer drug \u201cRibociclib\u201d.<\/p>\n

The petitioner, a retired Bank employee receiving a monthly pension of Rs. 28000, was diagnosed with HER2- Negative Metastatic Breast Cancer.<\/p>\n

The petitioner submitted that she is undergoing ‘targeted therapy’ treatment and the monthly cost of the medicines for treatment works out to Rs. 63,480 of which the costliest medicine is Ribociclib, which alone costs Rs. 58,140 per month.<\/p>\n

Ribociclib is not manufactured in India and according to the petitioner, if the medicine is manufactured in India, the cost will come down substantially and will be affordable to persons like the petitioner. Although, Ribociclib presently enjoys a patent monopoly, and its manufacturers are hence prevented from producing the medicine without the consent of the patent holder<\/span>.<\/p>\n

Referring to Section 92<\/a> of the Patents Act, 1970<\/a> which provides for a compulsory licence, and Section 100<\/a> which empowers the Government to requisition life-saving medicines in cases of extreme necessity, the petitioner had approached various authorities with a representation to make the life-saving drug available at affordable price.<\/p>\n

Though the petitioner had received an acknowledgement from the Union Ministry of Women and Child Development, her representation is still pending before the Department for Promotion of Industry and Internal Trade, New Delhi (Respondent-3). Therefore, as an interim measure, the petitioner had approached the Court seeking directions to the Industry and Internal Trade Department to consider her representation and take a reasoned decision without further delay.<\/p>\n

The Court noted that as per the available statistics, an alarming number of women succumb to breast cancer by reason of their inability to afford expensive treatment and medication. Referring to the Constitutional mandate, the Court stated that the right to life guaranteed under the Constitution, coupled with the State’s duty to improve public health, calls for emergent and effective action in the matter.<\/p>\n

Considering the seriousness of the matter, the Court directed Department for Promotion of Industry and Internal Trade (\u2018R-3′) to consider the petitioner’s representation and pass a reasoned order within four weeks after consultation with the other authorities.<\/p>\n

The matter is posted on 18-07-2022 for further hearing.<\/p>\n

[X v. Union of India, 2022 SCC OnLine Ker 3361<\/a>, decided on 14-06-2022<\/span>]<\/p>\n

\n

Advocates who appeared in this case :<\/p>\n

Maitreyi Sachidananda Hegde, Advocate, for the Petitioner.<\/p>\n<\/div>\n

\n

*Kamini Sharma, Editorial Assistant has reported this brief.<\/span><\/h4>\n","protected":false},"excerpt":{"rendered":"

Kerala High Court: While adjudicating a petition filed by a breast cancer patient seeking to afford life-saving medicines which otherwise cost more <\/p>\n","protected":false},"author":67011,"featured_media":269278,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3,10],"tags":[49926,49928,2523,49929,31395,49930,49927,5271,49932,49931],"class_list":["post-269277","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-casebriefs","category-highcourts","tag-breast-cancer","tag-compulsory-lincence","tag-Kerala_High_Court","tag-life-saving-medicine","tag-ministry-of-women-and-child-development","tag-patented-drugs","tag-patents-act-1970","tag-pension","tag-ribociclib","tag-women-health"],"yoast_head":"\nKerala High Court| Consider compulsory licensing of breast cancer drug Ribociclib; HC directs Central Government | SCC Times<\/title>\n<meta name=\"description\" content=\"breast cancer patient seeking to afford life-saving medicines which otherwise cost more than twice her monthly income\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kerala High Court| Consider compulsory licensing of breast cancer drug Ribociclib; HC directs Central Government\" \/>\n<meta property=\"og:description\" content=\"breast cancer patient seeking to afford life-saving medicines which otherwise cost more than twice her monthly income\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-30T05:30:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-07T11:18:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/kerla_high_court-3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1331\" \/>\n\t<meta property=\"og:image:height\" content=\"888\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/\",\"name\":\"Kerala High Court| Consider compulsory licensing of breast cancer drug Ribociclib; HC directs Central Government | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/kerla_high_court-3.jpg\",\"datePublished\":\"2022-06-30T05:30:41+00:00\",\"dateModified\":\"2022-07-07T11:18:34+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"breast cancer patient seeking to afford life-saving medicines which otherwise cost more than twice her monthly income\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/kerla_high_court-3.jpg\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/kerla_high_court-3.jpg\",\"width\":1331,\"height\":888,\"caption\":\"Kerala High Court\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kerala High Court| Consider compulsory licensing of breast cancer drug Ribociclib; HC directs Central Government\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Kerala High Court| Consider compulsory licensing of breast cancer drug Ribociclib; HC directs Central Government | SCC Times","description":"breast cancer patient seeking to afford life-saving medicines which otherwise cost more than twice her monthly income","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/","og_locale":"en_US","og_type":"article","og_title":"Kerala High Court| Consider compulsory licensing of breast cancer drug Ribociclib; HC directs Central Government","og_description":"breast cancer patient seeking to afford life-saving medicines which otherwise cost more than twice her monthly income","og_url":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2022-06-30T05:30:41+00:00","article_modified_time":"2022-07-07T11:18:34+00:00","og_image":[{"width":1331,"height":888,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/kerla_high_court-3.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Editor","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/","url":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/","name":"Kerala High Court| Consider compulsory licensing of breast cancer drug Ribociclib; HC directs Central Government | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/kerla_high_court-3.jpg","datePublished":"2022-06-30T05:30:41+00:00","dateModified":"2022-07-07T11:18:34+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"breast cancer patient seeking to afford life-saving medicines which otherwise cost more than twice her monthly income","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/kerla_high_court-3.jpg","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/kerla_high_court-3.jpg","width":1331,"height":888,"caption":"Kerala High Court"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2022\/06\/30\/kerala-high-court-consider-compulsory-licensing-of-breast-cancer-drug-ribociclib-hc-directs-central-government\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Kerala High Court| Consider compulsory licensing of breast cancer drug Ribociclib; HC directs Central Government"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/06\/kerla_high_court-3.jpg","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":279236,"url":"https:\/\/www.scconline.com\/blog\/post\/2022\/12\/07\/karnataka-hc-healthcare-global-enterprises-loss-of-profit-due-to-price-regularisation-of-essential-anti-cancer-drugs-is-not-a-ground-for-judicial-review-of-a-government-policy\/","url_meta":{"origin":269277,"position":0},"title":"Karnataka HC | Healthcare Global Enterprises\u2019 loss of profit due to price regularisation of essential anti-cancer drugs, is not a ground for judicial review of a Government Policy","author":"Editor","date":"December 7, 2022","format":false,"excerpt":"A Government Order regulating, and rationalising prices of essential anti-cancer drugs was challenged before the Karnataka HC. The Court clearly stated that the challenge vis-a-vis petitioner's loss of profit, cannot be sustained","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Karnataka High Court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/11\/Karnataka-High-Court-2-1.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":256592,"url":"https:\/\/www.scconline.com\/blog\/post\/2021\/11\/01\/court-allows-pil-highlighting-delay-in-establishing-comprehensive-and-modern-cancer-care-facilities-in-the-state\/","url_meta":{"origin":269277,"position":1},"title":"Megh HC | Court allows PIL highlighting delay in establishing comprehensive and modern cancer care facilities in the State","author":"Editor","date":"November 1, 2021","format":false,"excerpt":"Meghalaya High Court: The Division Bench of Ranjit More, CJ. and H.S.Thangkhiew, J., took up a petition which prayed for the following: a writ in the nature of mandamus directing the Respondent\u2019s authorities to utilize the amount of Rs. 19.84 crore received by the State Respondents and to constitute inquiry\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":18429,"url":"https:\/\/www.scconline.com\/blog\/post\/2015\/10\/09\/biotech-invention-through-which-vulnerability-to-cancer-can-be-detected-held-to-be-non-patentable\/","url_meta":{"origin":269277,"position":2},"title":"Biotech invention through which vulnerability to cancer can be detected held to be non-patentable","author":"Sucheta","date":"October 9, 2015","format":false,"excerpt":"High Court of Australia: In a pivotal issue relating to claim of patent of isolated nucleic acid coding for BRCA1 protein with specifies mutations or polymorphisms indicative of susceptibility to cancer, the Court held them as non-patentable. The present petition was based on three claims i.e. (1); whether invention claimed\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2015\/10\/scc-blog_Page_9.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2015\/10\/scc-blog_Page_9.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2015\/10\/scc-blog_Page_9.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2015\/10\/scc-blog_Page_9.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2015\/10\/scc-blog_Page_9.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":338220,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/12\/31\/power-to-call-records-revise-penalty-order-after-consultation-with-psc-is-on-governor-discretion-sikkim-hc\/","url_meta":{"origin":269277,"position":3},"title":"\u2018Power to revise penalty after consultation with PSC is on Governor\u2019s discretion\u2019; Sikkim HC upholds order modifying penalty of dismissal from service to compulsory retirement","author":"Editor","date":"December 31, 2024","format":false,"excerpt":"The Governor\u2019s failure to consult the Commission as envisaged in Rule 10 of Sikkim Government Servants\u2019 (Discipline and Appeal) Rules, 1985, while passing the order modifying the penalty, alone would not change the nature of the case.","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Sikkim High Court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/04\/Sikkim-High-Court.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/04\/Sikkim-High-Court.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/04\/Sikkim-High-Court.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/04\/Sikkim-High-Court.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":261215,"url":"https:\/\/www.scconline.com\/blog\/post\/2022\/02\/05\/whether-state-empowered-to-reject-medical-reimbursement-for-treatment-being-from-unrecognized-department-of-recognized-hospital\/","url_meta":{"origin":269277,"position":4},"title":"Ker HC | Whether State empowered to reject medical reimbursement for treatment being from unrecognized department of recognized hospital? HC decides\u00a0\u00a0 \u00a0\u00a0\u00a0","author":"Editor","date":"February 5, 2022","format":false,"excerpt":"Kerala High Court: Murali Purushothaman, J., held that there is a Constitutional as well a statutory obligation on the part of the State to bear the expenses for treatment of the government servant and his family. Background The petitioner, an Assistant Professor in Catholicate College had took his father, who\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":267064,"url":"https:\/\/www.scconline.com\/blog\/post\/2022\/05\/19\/endosuflan-victims-compensation-kerala-government-five-years-supreme-court-contempt-legal-news-research-knowledge-updates\/","url_meta":{"origin":269277,"position":5},"title":"SC finds Kerala Govt’s failure to compensate 3700 Endosulfan victims for 5 years appalling; says “without health, the faculties of living have little meaning”","author":"Prachi Bhardwaj","date":"May 19, 2022","format":false,"excerpt":"Supreme Court: In the issue relating to the use of a toxic pesticide called Endosulfan leading to a spread of mental and physical ailments among residents of Kasargod district in Kerala, the bench of Dr. DY Chandrachud* and Surya Kant, JJ has held that the inordinate delay by the State\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/05\/MicrosoftTeams-image-175.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/05\/MicrosoftTeams-image-175.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/05\/MicrosoftTeams-image-175.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/05\/MicrosoftTeams-image-175.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/05\/MicrosoftTeams-image-175.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/269277","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=269277"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/269277\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/269278"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=269277"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=269277"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=269277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}